全文获取类型
收费全文 | 4189篇 |
免费 | 202篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 78篇 |
儿科学 | 76篇 |
妇产科学 | 158篇 |
基础医学 | 562篇 |
口腔科学 | 118篇 |
临床医学 | 427篇 |
内科学 | 683篇 |
皮肤病学 | 125篇 |
神经病学 | 314篇 |
特种医学 | 261篇 |
外科学 | 713篇 |
综合类 | 26篇 |
一般理论 | 1篇 |
预防医学 | 230篇 |
眼科学 | 46篇 |
药学 | 361篇 |
中国医学 | 2篇 |
肿瘤学 | 225篇 |
出版年
2021年 | 35篇 |
2020年 | 35篇 |
2019年 | 52篇 |
2018年 | 59篇 |
2017年 | 40篇 |
2016年 | 61篇 |
2015年 | 74篇 |
2014年 | 99篇 |
2013年 | 139篇 |
2012年 | 209篇 |
2011年 | 218篇 |
2010年 | 111篇 |
2009年 | 97篇 |
2008年 | 180篇 |
2007年 | 168篇 |
2006年 | 166篇 |
2005年 | 155篇 |
2004年 | 139篇 |
2003年 | 189篇 |
2002年 | 178篇 |
2001年 | 142篇 |
2000年 | 180篇 |
1999年 | 149篇 |
1998年 | 50篇 |
1997年 | 46篇 |
1996年 | 28篇 |
1995年 | 24篇 |
1994年 | 25篇 |
1993年 | 23篇 |
1992年 | 86篇 |
1991年 | 79篇 |
1990年 | 66篇 |
1989年 | 89篇 |
1988年 | 80篇 |
1987年 | 76篇 |
1986年 | 68篇 |
1985年 | 63篇 |
1984年 | 57篇 |
1983年 | 56篇 |
1982年 | 34篇 |
1981年 | 29篇 |
1980年 | 22篇 |
1979年 | 42篇 |
1978年 | 38篇 |
1977年 | 32篇 |
1975年 | 40篇 |
1974年 | 30篇 |
1973年 | 44篇 |
1972年 | 40篇 |
1971年 | 27篇 |
排序方式: 共有4406条查询结果,搜索用时 15 毫秒
1.
2.
Martin Freesmeyer Christian Kühnel Falk Gühne Philipp Seifert 《Journal of ultrasound in medicine》2019,38(12):3311-3319
Fine‐needle aspiration cytology using a novel ultrasound needle guidance system on the basis of standard needle magnetization was consecutively performed in 30 (15 in‐plane and 15 out‐of‐plane) suspicious thyroid nodules. Nondedicated, commercially available needles were used. The technical effectiveness and safety of the system were satisfying; system failures were observed in 2 cases. The needle tip could be (at least occasionally) visualized inside the thyroid nodule in 96%, and the subjective procedure ratings were excellent in 57%. The out‐of‐plane technique was significantly superior in both respects (P = .021 and .027, respectively). Standard needle magnetization ultrasound needle guidance was easy to apply and cost‐effective and has the potential to improve fine‐needle aspiration cytology performance. 相似文献
3.
Robert A. Mischkowski Max J. Zinser Alexander C. Kübler Barbara Krug Ulrich Seifert Joachim E. Zller 《Journal of cranio-maxillo-facial surgery》2006,34(8):478-483
BACKGROUND: An augmented reality tool for computer assisted surgery named X-Scope allows visual tracking of real anatomical structures in superposition with volume rendered CT or MRI scans and thus can be used for navigated translocation of bony segments. METHODS: In a feasibility study X-Scope was used in orthognathic surgery to control the translocation of the maxilla after Le Fort I osteotomy within a bimaxillary procedure. The situation achieved was compared with the pre-operative situation by means of cephalometric analysis on lateral and frontal cephalograms. RESULTS: The technique was successfully utilized in 5 patients. Maxillary positioning using X-Scope was accomplished accurately within a range of 1mm. The tool was used in all cases in addition to the usual intra-operative splints. A stand-alone application without conventional control does not yet seem reasonable. CONCLUSION: Augmented reality tools like X-Scope may be helpful for controlling maxillary translocation in orthognathic surgery. The application to other interventions in cranio-maxillofacial surgery such as Le Fort III osteotomy, fronto-orbital advancement, and cranial vault reshaping or repair may also be considered. 相似文献
4.
Prevention of Bone Loss by Clodronate in Early Postmenopausal Women with Vertebral Osteopenia: A Dose-Finding Study 总被引:1,自引:0,他引:1
M. J. V?lim?ki K. Laitinen K. Laitinen A. Patronen H. Puolijoki H. Puolijoki J. Sepp?nen L. Pylkk?nenand the Probone Study Group 《Osteoporosis international》2002,13(12):937-947
This double-masked, placebo-controlled study was undertaken to determine the efficacy and safety of oral clodronate in the
prevention of bone loss in early postmenopausal women with vertebral osteopenia. Altogether 610 women with a mean age of 53
years were recruited for the study. They were 1–5 years postmenopausal and their lumbar spine bone mineral density (BMD) was
at least 1 standard deviation below the mean of premenopausal women (T-score ≤−1). The subjects were randomized into five study groups to receive either placebo, clodronate 65 mg, 400 mg or 800
mg daily, or intermittent clodronate in 3 month cycles with 400 mg daily for 15 days followed with no treatment for 75 days
for 3 years. One hundred and eighty-seven of 509 women who completed the primary study continued in the extension study of
2 years in which previous placebo users were switched to clodronate 800 mg daily, while previous users of 400 mg or 800 mg
of clodronate used either placebo or 800 mg of clodronate daily. In the primary study clodronate was administered in the evening,
and in the extension 1 h before breakfast on an empty stomach. In the primary study mean changes in lumbar spine BMD were
−3.4% in the placebo group and +0.4% in 800 mg clodronate group [difference between groups at 3 years 3.8% (95% CI 2.7% to
4.9%, p<0.0001)], and in the trochanter area BMD −1.1% in the placebo group, and + 0.4% in the 800 mg clodronate group [difference
between groups at 3 years 1.5% (95% CI 0.05% to 2.9%)]. During the extension study mean changes in lumbar spine BMD were +1.5%
in the clodronate group and −0.2 % in the placebo group [difference between groups 1.7% (CI 0.4% to 3.0%, p = 0.010)] and in trochanter BMD were +2.5% in the clodronate group and no change in the placebo group [difference between
groups 2.1% (CI 0.3% to 3.9%, p = 0.007)]. No statistically significant differences between the placebo and 800 mg clodronate groups were found in the femoral
neck BMD. In the primary study the urinary excretion of type I collagen aminoterminal telopeptide (NTX) decreased by 44% (p<0.0001 compared with placebo) and that of deoxypyridinoline by 18% (p<0.0001) in the clodronate 800 mg group. In the extension study urinary NTX decreased by 51% (p<0.0001) in those who were switched to 800 mg of clodronate and increased by 67% (p<0.0001) in those who stopped using that dose. There was no difference in the frequency of gastrointestinal complaints between
clodronate- and placebo-treated patients in the primary study, but they were more common among women who received clodronate
in the extension phase. Clodronate in daily doses of 400–800 mg caused a slight elevation of aminotransferase levels, usually
within the reference range. In bone biopsies no defect in mineralization was found. In conclusion, clodronate in a daily dose
of 800 mg prevents early postmenopausal bone loss at the sites of the skeleton in which cancellous bone predominates. It effectively
reduces bone resorption and bone turnover rate. Antifracture efficacy of clodronate remains to be established by prospective,
placebo-controlled trials.
Received: 4 March 2002 / Accepted: 9 July 2002 相似文献
5.
6.
7.
8.
9.
J Uusi-Simola T Serén T Sepp?l? A Kosunen I Auterinen S Savolainen 《Applied radiation and isotopes》2004,61(5):845-848
Tissue equivalent proportional counter microdosimetry has been applied in the dosimetry of epithermal neutron beams as they can provide an independent and accurate method to determine gamma ray and neutron absorbed doses. Dosimetric comparison has been performed using a tissue equivalent proportional counter, dual ionisation chambers and DORT computer code at FiR 1 boron neutron capture therapy facility in Espoo, Finland. The three methods were applied to determine neutron and gamma ray absorbed doses at 25, 40, 60 and 120 mm depths along the beam centerline in a water-filled PMMA phantom. The determined absorbed doses were found to agree within the limits of the estimated uncertainties. 相似文献
10.